Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
Organogenesis (ORGO) - P/B ratio
P/B ratio as of April 2024 : 1.11
According to Organogenesis's latest financial reports the company has a price-to-book ratio of 1.11.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Organogenesis - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.93 | 45.4% |
| 2022-12-31 | 1.33 | -73.09% |
| 2021-12-31 | 4.93 | -27.38% |
| 2020-12-31 | 6.78 | -25.26% |
| 2019-12-31 | 9.08 | -54.28% |
| 2018-12-31 | 19.8 | -155.22% |
| 2017-12-31 | -35.9 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6322 | -43.20% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | 29.40% | 🇺🇸 USA |